Cargando…
Vasopressin vs Terlipressin in Treatment of Refractory Shock
Arginine vasopressin (AVP) and its synthetic, long-acting analog terlipressin (TP) are potent alternative vasoconstrictors in the treatment of septic patients with catecholamine-refractive vasodilatatory shock. Recent clinical data suggest that early administration of AVP analogues may be advantageo...
Autores principales: | Scarpati, G, Piazza, O |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università di Salerno
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728816/ https://www.ncbi.nlm.nih.gov/pubmed/23905079 |
Ejemplares similares
-
Vasopressin and terlipressin in adult vasodilatory shock
por: Polito, Angelo, et al.
Publicado: (2012) -
Clinical review: Vasopressin and terlipressin in septic shock patients
por: Delmas, Anne, et al.
Publicado: (2005) -
Vasopressin analog terlipressin attenuates kidney injury in hemorrhagic shock
por: Cardoso de Castro, Letícia Urbano, et al.
Publicado: (2016) -
Continuous terlipressin versus vasopressin infusion in septic shock: the TERLIVAP study
por: Morelli, A, et al.
Publicado: (2008) -
Vasopressin and terlipressin as first-line therapy in fulminant ovine septic shock
por: Rehberg, S, et al.
Publicado: (2008)